{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:02:14Z","timestamp":1791054134258,"version":"4.1.0"},"reference-count":68,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T00:00:00Z","timestamp":1094601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Opioid receptors in the gastrointestinal (GI) tract mediate the effects of endogenous opioid peptides and exogenously administered opioid analgesics, on a variety of physiological functions associated with motility, secretion and visceral pain. The studies reviewed or reported here describe a range of in vivo activities of opioid receptor antagonists upon GI function in rodents, focusing on \u00b5 receptors. Naloxone, and the peripherally acting \u00b5\u2010opioid receptor antagonists alvimopan and methylnaltrexone, reverse morphine\u2010induced inhibition of GI transit in mice and rats, and morphine\u2010 or loperamide\u2010induced inhibition of castor oil\u2010induced diarrhoea in mice. At doses producing maximal reversal of morphine\u2010induced effects upon GI transit, only the central nervous system (CNS) penetrant antagonist naloxone was able to reverse morphine\u2010induced analgesia. Both central and peripheral opioid antagonists may affect GI function and\/or visceromotor sensitivity in the absence of exogenous opioid analgesics, suggesting a constitutive role for endogenous opioid peptides in the control of GI physiology. Furthermore, in contrast to naloxone, alvimopan does not produce hypersensitivity to the visceromotor response induced by nociceptive levels of colorectal distension in a rodent model of postinflammatory colonic hypersensitivity, suggesting that in the periphery endogenous \u03bc\u2010opioid receptor\u2010mediated mechanisms do not regulate colonic sensitivity. The data support the hypothesis that peripherally acting opioid antagonists may be able to selectively block opioid receptors in the GI tract, thereby preserving normal GI physiology, while not blocking the effects of endogenous opioid peptides or exogenous opioid analgesics in the CNS. These findings suggest that the primary sites of action of \u00b5\u2010opioid agonists with respect to inhibition of GI function are in the periphery, whereas analgesic activity resides primarily in the CNS.<\/jats:p>","DOI":"10.1111\/j.1743-3150.2004.00555.x","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T10:34:25Z","timestamp":1094639665000},"page":"46-53","source":"Crossref","is-referenced-by-count":76,"title":["Preclinical studies of opioids and opioid antagonists on gastrointestinal function"],"prefix":"10.1111","volume":"16","author":[{"given":"B.","family":"Greenwood\u2010Van Meerveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Dehaven\u2010Hudkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,8]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363070-00003"},{"key":"e_1_2_9_3_2","first-page":"121","article-title":"Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion","volume":"40","author":"Kromer W.","year":"1988","journal-title":"Pharmacol Rev"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-3150.2004.00553.x"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-3150.2004.00554.x"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-3150.2004.00556.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00869-3"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70234-9"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9861(20010129)430:1<1::AID-CNE1011>3.0.CO;2-H"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703219"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01862644"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(88)90024-3"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90748-V"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1054\/npep.1999.0789"},{"key":"e_1_2_9_15_2","first-page":"965","article-title":"Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N\u2010channels","volume":"268","author":"Kojima Y","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1990.sp018340"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb13193.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00411-7"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01295711"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2001.281.1.G124"},{"key":"e_1_2_9_21_2","first-page":"1068","article-title":"Peripheral effects of opioids in a model of chronic intestinal inflammation in mice","volume":"287","author":"Puig MM","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_22_2","first-page":"894","article-title":"Inflammation enhances \u00b5\u2010opioid receptor transcription and expression in mice intestine","volume":"60","author":"Pol O","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01281-X"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.049346"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00275-J"},{"key":"e_1_2_9_26_2","first-page":"1007","article-title":"Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat","volume":"124","author":"Zhuo M","year":"2002","journal-title":"J Neurophysiol"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00469-4"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06675.x"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199508000-00015"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199508000-00014"},{"key":"e_1_2_9_31_2","first-page":"707","article-title":"Effects of kappa\u2010opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation","volume":"285","author":"Burton MB","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00360.x"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(96)00647-9"},{"key":"e_1_2_9_34_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59259-202-9_8","volume-title":"Drug Development \u2212Molecular Targets for GI Diseases","author":"Rivi\u00e8re PJM","year":"2000"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70064-1"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.78.2.1003"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00624.2001"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/rapm.2000.18187"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70226-X"},{"key":"e_1_2_9_40_2","first-page":"171","article-title":"The peripherally acting \u03ba\u2010opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity","volume":"21","author":"Gottschlich R","year":"1995","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17142.x"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00175-4"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2000.83.4.2209"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00360.2002"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.052829"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(85)90188-9"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(85)90072-3"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(83)90246-0"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00783-8"},{"key":"e_1_2_9_50_2","first-page":"8","article-title":"Independent central and peripheral mediation of morphine\u2010induced inhibition of gastrointestinal transit in rats","volume":"236","author":"Gmerek DE","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498258909043176"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431767"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(85)90345-2"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90026-7"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2299(200006)50:2<133::AID-DDR1>3.0.CO;2-8"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00784-X"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00041a003"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1994.019.12.276933"},{"key":"e_1_2_9_59_2","first-page":"554.7","article-title":"Characterization of [3H]alvimopan binding to the cloned human \u00b5 opioid receptor","volume":"28","author":"Cassel JA","year":"2002","journal-title":"Soc Neurosci Abstract"},{"key":"e_1_2_9_60_2","first-page":"238.13","article-title":"Inhibition of opioid receptor\u2010mediated [35S]GTP\u03b3S binding by ADL 8\u20132698, a potent opioid receptor antagonist","volume":"26","author":"Daubert JD","year":"2000","journal-title":"Soc Neurosci Abstract"},{"key":"e_1_2_9_61_2","first-page":"1706","article-title":"Effects of novel \u00b5 opioid antagonists on gastrointestinal (GI) transit in mice","volume":"25","author":"Long SL","year":"1999","journal-title":"Soc Neurosci Abstract"},{"key":"e_1_2_9_62_2","unstructured":"LittlePJ LongSL GottshallSL KoblishM GuoD DeHaven\u2010HudkinsDL.Pharmacological profile of ADL 8\u20132698 a peripherally restricted opioid receptor antagonist. International Narcotics Research Conference Seattle WA July 15\u201320 2000."},{"key":"e_1_2_9_63_2","first-page":"907.2","article-title":"ADL 8\u20132698, a GI restricted opioid antagonist, blocks the antisecretory and colorectal transit effects of morphine and loperamide","volume":"27","author":"Little PJ","year":"2001","journal-title":"Soc Neurosci Abstract"},{"key":"e_1_2_9_64_2","first-page":"907.3","article-title":"Behavioral profile of ADL 8\u20132698, a novel GI\u2010restricted \u00b5 opioid receptor antagonist","volume":"27","author":"Koblish M","year":"2001","journal-title":"Soc Neurosci Abstract"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-3150.2004.00557.x"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.2.202"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)82992-2"},{"key":"e_1_2_9_68_2","first-page":"66","article-title":"ADL 8\u20132698, a trans\u20103,4\u2010dimethyl\u20104\u2010(3\u2010hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia","volume":"68","author":"Liu SS","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010564"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1743-3150.2004.00555.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1743-3150.2004.00555.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T13:36:39Z","timestamp":1695821799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1743-3150.2004.00555.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,8]]},"references-count":68,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1743-3150.2004.00555.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1743-3150.2004.00555.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,8]]}}}